Furthermore, expression analysis of two different datasets of breast cancer cell lines suggests cancer subtype-dependent regulation of α3 expression, with its downregulation in invasive HER2+ luminal-like carcinoma cells. The gene discussed is ERBB2; the disease is breast cancer.